Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib

Author

Jaramillo, Sonia

Scherer, Michael

Szu-Tu, Chelsea

Beneyto Calabuig, Sergi

Müller-Tidow, Carsten

Schlenk, Richard F.

Hundemer, Michael

Pabst, Caroline

Publication date

2025-01-22T07:24:27Z

2025-01-22T07:24:27Z

2024

Document Type

Article

Published version

Language

English

Subjects and keywords

Leucèmia mieloide aguda

Publisher

Ferrata Storti Foundation

Related items

Haematologica. 2024 Nov 1;109(11):3811-5

Recommended citation

This citation was generated automatically.

Export

DIDL MARC MARC_CCUC METS OAI_DC ORE QDC RDF

Rights

Copyright (c) 2024 Ferrata Storti Foundation. This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/).

http://creativecommons.org/licenses/by-nc/4.0/

This item appears in the following Collection(s)

Recerca: articles, congressos, llibres [21033]